Transferable data exclusivity vouchers are not the solution to the antimicrobial drug development crisis: a commentary on the proposed EU pharma regulation
Saved in:
| Main Authors: | Till Bärnighausen, Albrecht Jahn, Astrid Berner-Rodoreda, Frank Cobelens, Mario Raviglione, Jolene Skordis, Anne-Mieke Vandamme, Günter Froeschl, Elil Renganathan, Ellen t’Hoen |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2024-02-01
|
| Series: | BMJ Global Health |
| Online Access: | https://gh.bmj.com/content/9/2/e014605.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The EU global health strategy: from policy to implementation
by: Jolene Skordis, et al.
Published: (2025-02-01) -
Balancing Equity and Global Health Security Towards a Fair and Effective Pandemic Agreement
by: Elil Renganathan, et al.
Published: (2025-04-01) -
Where is the ‘global’ in the European Union’s Health Research and Innovation Agenda?
by: Till Bärnighausen, et al.
Published: (2019-10-01) -
Correction: EGHRIN conclusions on pandemic preparedness: no whole-of-society approach without society
by: Marie Stockman, et al.
Published: (2025-07-01) -
EGHRIN conclusions on pandemic preparedness: no whole-of-society approach without society
by: Marie Stockman, et al.
Published: (2024-12-01)